380 related articles for article (PubMed ID: 11782708)
1. [New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].
Colao A; Pulcrano M; Dorato M; Müller F; Rossi FW; De Martino MC; Biondi B; Lombardi G
Minerva Endocrinol; 2001 Dec; 26(4):231-8. PubMed ID: 11782708
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment of endocrine gastroenteropancreatic tumors.
Tomassetti P; Campana D; Nori F; Piscitelli L; Salomone L; Pezzilli R; Corinaldesi R
JOP; 2006 Jan; 7(1):145-9. PubMed ID: 16407637
[No Abstract] [Full Text] [Related]
3. [Efficacy of somatostatin analogs in the treatment of neuroendocrine tumours and paraneoplastic syndromes].
Sperlongano P; De Falco M; Pisaniello D; Parmeggiani D; Parmeggiani U
Minerva Endocrinol; 2001 Dec; 26(4):293-5. PubMed ID: 11782719
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of neuroendocrine tumours of the gastrointestinal tract].
Hansen CP; Langer S; Frevert S; Mortensen J; Kjaer A; Knigge U
Ugeskr Laeger; 2010 Oct; 172(43):2942-5. PubMed ID: 21040671
[TBL] [Abstract][Full Text] [Related]
5. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for gastro-enteropancreatic endocrine tumours.
O'Toole D; Hentic O; Corcos O; Ruszniewski P
Neuroendocrinology; 2004; 80 Suppl 1():79-84. PubMed ID: 15477723
[TBL] [Abstract][Full Text] [Related]
7. [Neuroendocrine tumours of the gastrointestinal tract].
Plöckinger U; Wiedenmann B
Z Gastroenterol; 2004 Jun; 42(6):517-27. PubMed ID: 15190448
[TBL] [Abstract][Full Text] [Related]
8. Advances in chemotherapy and biotherapy of endocrine tumors.
Oberg K
Curr Opin Oncol; 1998 Jan; 10(1):58-65. PubMed ID: 9466486
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors.
Oberg K
Expert Rev Anticancer Ther; 2009 May; 9(5):557-66. PubMed ID: 19445573
[TBL] [Abstract][Full Text] [Related]
10. [Somatostatin analogues for the treatment of gastro-entero-pancreatic neuroendocrine tumours].
Uomo G; Germano D; Rabitti PG
Minerva Endocrinol; 2001 Dec; 26(4):225-9. PubMed ID: 11782707
[TBL] [Abstract][Full Text] [Related]
11. State of the art and future prospects in the management of neuroendocrine tumors.
Oberg K
Q J Nucl Med; 2000 Mar; 44(1):3-12. PubMed ID: 10932597
[TBL] [Abstract][Full Text] [Related]
12. Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.
Janson ET; Sørbye H; Welin S; Federspiel B; Grønbaek H; Hellman P; Mathisen O; Mortensen J; Sundin A; Thiis-Evensen E; Välimäki MJ; Oberg K; Knigge U
Acta Oncol; 2010 Aug; 49(6):740-56. PubMed ID: 20553100
[TBL] [Abstract][Full Text] [Related]
13. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
Hofsli E
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
[TBL] [Abstract][Full Text] [Related]
14. Endocrine tumors of the gastrointestinal tract: systemic treatment.
Oberg K
Anticancer Drugs; 1994 Oct; 5(5):503-19. PubMed ID: 7858282
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced endocrine gastroenteropancreatic tumours using radiolabelled somatostatin analogues.
Van Eijck CH
Br J Surg; 2005 Nov; 92(11):1333-4. PubMed ID: 16237740
[No Abstract] [Full Text] [Related]
16. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
[TBL] [Abstract][Full Text] [Related]
17. Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours.
Srirajaskanthan R; Toumpanakis C; Meyer T; Caplin ME
Aliment Pharmacol Ther; 2009 Jun; 29(11):1143-54. PubMed ID: 19298583
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours.
Khan MS; Caplin ME
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S53-74. PubMed ID: 22005115
[TBL] [Abstract][Full Text] [Related]
19. New directions in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): shifting from symptom management to targeting tumors.
Weber M
Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):12-7. PubMed ID: 25768104
[No Abstract] [Full Text] [Related]
20. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview.
Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M;
Acta Oncol; 2004; 43(7):617-25. PubMed ID: 15545182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]